Moexipril
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| (3S)-2-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | |
| Clinical data | |
| Trade names | Univasc |
| AHFS/Drugs.com | monograph |
| MedlinePlus | a695018 |
| Pregnancy cat. | D(US) |
| Legal status | POM (UK) ℞-only (US) |
| Routes | Oral |
| Identifiers | |
| CAS number | 103775-10-6  |
| ATC code | C09AA13 |
| PubChem | CID 91270 |
| DrugBank | DB00691 |
| ChemSpider | 82418  |
| UNII | WT87C52TJZ |
| KEGG | D08225 |
| ChEMBL | CHEMBL1165 |
| Chemical data | |
| Formula | C27H34N2O7 |
| Mol. mass | 498.568 g/mol |
 (what is this?) (verify) |
|
Moexipril (marketed under the tradenames Univasc and Perdix[1]) is an ACE inhibitor.[2]
[edit] References
- ^ Dart, Richard C. (2004). Medical toxicology. Lippincott Williams & Wilkins. p. 647. ISBN 9780781728454. http://books.google.ca/books?id=BfdighlyGiwC&pg=PA647. Retrieved 2009-10-09.
- ^ Hochadel, Maryanne, ed (2006). The AARP Guide to Pills. Sterling Publishing Company. p. 640. ISBN 9781402717406. http://books.google.ca/books?id=WvcaI-7TuaMC&pg=RA1-PA64. Retrieved 2009-10-09.
|
||||||||||||||||
 |
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
